Red Fluorescent Protein Biosensor for Dopamine D1 Selectivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing sensors lack selectivity in measuring the activity of dopamine receptor subtypes, particularly for dopamine receptor D1, and are not effective in detecting ligand binding, which is crucial for understanding neurological diseases.
Innovation Solution
A red fluorescent protein-based biosensor is developed, comprising a recombinant gene with a dopamine receptor D1 gene and a gene encoding a modified red fluorescent protein, which is introduced into cells to measure the activity of dopamine receptor D1 and detect ligand binding by changes in fluorescence intensity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If existing sensors are used to measure dopamine receptor activity, then sensitivity is improved, but selectivity for dopamine receptor subtypes deteriorates
Solution Approach 1:
The invention segments the measurement function by creating separate biosensor systems for different dopamine receptor subtypes (D1, D2, D3, D4, D5). Each biosensor is specifically designed to detect only its target subtype through selective ligand binding, thereby achieving high selectivity while maintaining sensitivity through the use of fluorescent protein signals.
Solution Approach 2:
The invention applies local quality by endowing each biosensor with subtype-specific recognition properties. The ligand binding domain of each biosensor is tailored to recognize only its corresponding dopamine receptor subtype, creating localized specificity while the fluorescent protein component provides universal sensitive detection capability.
2Reliability
If existing sensors are used to detect ligand binding, then general detection capability is improved, but subtype-specific detection deteriorates
Solution Approach 1:
The invention achieves universality by using a common fluorescent protein-based detection mechanism across all dopamine receptor subtype biosensors. This universal signaling platform provides reliable detection capability, while the subtype-specific ligand binding domains ensure precise subtype identification, combining both general reliability and specific precision.
Solution Approach 2:
The invention utilizes parameter changes by varying the ligand binding specificity parameter for each biosensor subtype while maintaining the fluorescent detection parameter. This allows each biosensor to be tuned for its specific target subtype while preserving the reliable fluorescent signal output for detection.
3Measurement precision
If a recombinant gene system is used to create the biosensor, then selectivity for dopamine receptor D1 is improved, but device complexity increases
Solution Approach 1:
The invention replaces complex mechanical or chemical sensor construction with a biological system based on recombinant gene expression. By substituting the detection mechanism with genetically encoded fluorescent proteins that respond to dopamine receptor activation, the system achieves high selectivity through molecular recognition while simplifying the overall device architecture.
Solution Approach 2:
The recombinant gene system enables self-service by allowing cells to autonomously produce the biosensor components. The host cells express the fusion protein containing the dopamine receptor D1 extracellular domain and fluorescent protein, eliminating the need for external sensor assembly and reducing device complexity while maintaining high selectivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biosensor effectively measures the activity of dopamine receptor D1 with high selectivity and sensitivity, allowing for accurate detection of ligand binding, even at low concentrations, and differentiates between dopamine receptor subtypes.
Implementation Method 1
a gene encoding a red fluorescent protein or a modified red fluorescent protein
Data Source
AI summary
Provided are a red fluorescent protein-based biosensor for measuring the activity of dopamine receptor D1, a method of measuring the activity of dopamine receptor D1 using the biosensor, and a method of detecting a ligand binding to dopamine receptor D1.